## Prompt 3rd.md - Claude Code Opus 4.6 02/14/26

Please use the same approach as the last conversation and pull request to create py, html, and png files to complete your tasks in a timely manner (and avoid your output from stalling during image generations). No changelog or release notes are needed. Keep both interactive and png directories, and have new directories “3rd” (the current PR files) under both the interactive and png directories. 

Based on the following 10 sets of instructions, using Python Plotly or similar approaches, create high quality and comprehensive interactive visualization scripts that correspond with easy access to view the scripts in html in both light mode and dark mode for “interactive” that will also output 20 high resolution .png diagrams/charts, etc. in “png”. It is important that visualizations be self standing, as some less effective visualizations will be removed by the user if ineffective. 

The visualizations detail processes, methods, mechanisms, and metrics critical for engineers building physical AI oncology trials. It is important not to use file name number prefixes such as 21 or 30, as some images may be removed by the user. Use the following 10 sets of instructions as a guide only, making sure the accuracy and relevance of recent data and effectiveness of visualizations come through extensive analysis for correct context of the current version of the repository. Be sure to fix and address errors that would cause failed checks for the pull request (the most prior PR made sure the Python environment is correct to avoid the following error during final checks): “3 failing checks 
x Cl / lint-and-format (3.10) (pull...
x Cl / lint-and-format (3.11) (pull...
x Cl / lint-and-format (3.12) (pull... “ When you are finished, provide a list of new additions and what changed from old to new files. The user will then review your lists prior to committing changes. Do not make changes to changelog or release notes.

“Start Instructions”

## Instruction 21 — Federated Learning Convergence Across Hospital Sites

**Chart type:** Dual-panel line chart (left: loss, right: accuracy) with per-site traces (`make_subplots`, `go.Scatter`)

**Title:** `"Federated Learning Convergence: ONCO-FED-001 Trial (3 Hospital Sites, 5 Rounds)"`

**Purpose:** Visualize how the federated model converges across geographically distributed hospital sites without sharing patient data, showing per-site and aggregate performance metrics.

**Data source files:**
- `federation/federated_coordinator.py` — Contains `FederationConfig` dataclass with `trial_name="ONCO-FED-001"`, `aggregation_strategy="fedavg"`, default `num_rounds=5`, `learning_rate=0.01`, `convergence_threshold=1e-4`. Also contains `_aggregate_fedavg()` method implementing weighted averaging by patient count. Contains `SimulatedLocalTrainer` with `noise_scale=0.1`.
- `federation/examples-federation/01_basic_two_site.py` — Basic two-site example
- `federation/examples-federation/06_full_consortium.py` — Full consortium example

**Left panel:**
- X-axis: `"Federation Round"`
- Y-axis: `"Average Loss"`

**Right panel:**
- X-axis: `"Federation Round"`
- Y-axis: `"Average Accuracy"`

**Data to plot (from federated_coordinator.py simulated metrics):**
| Round | Avg Loss | Avg Accuracy | Site 1 Loss (100 pts) | Site 2 Loss (150 pts) | Site 3 Loss (120 pts) |
|---|---|---|---|---|---|
| 0 | 2.341 | 0.312 | 2.45 | 2.30 | 2.27 |
| 1 | 1.856 | 0.456 | 1.92 | 1.80 | 1.85 |
| 2 | 1.523 | 0.578 | 1.58 | 1.49 | 1.50 |
| 3 | 1.234 | 0.687 | 1.30 | 1.20 | 1.20 |
| 4 | 1.045 | 0.756 | 1.10 | 1.00 | 1.03 |
| 5 | 0.987 | 0.801 | 1.02 | 0.96 | 0.98 |

Site weights: Site 1 = 100/370 = 0.27, Site 2 = 150/370 = 0.41, Site 3 = 120/370 = 0.32.

Show per-site traces as thin dashed lines, aggregate as thick solid line. Annotate convergence at Round 5: "ΔL = 0.058 < threshold".

**Light mode:** `plotly_white`, Site 1=blue, Site 2=green, Site 3=orange, Aggregate=black.
**Dark mode:** `plotly_dark`, Site 1=cyan, Site 2=lime, Site 3=gold, Aggregate=white.

---

## Instruction 22 — Multi-Site Clinical Trial Enrollment & Quality Dashboard

**Chart type:** Heatmap table with color-coded status cells (`go.Table` with conditional cell colors, or `ff.create_annotated_heatmap`)

**Title:** `"Multi-Site Trial Monitoring Dashboard: Enrollment & Data Quality Metrics"`

**Purpose:** Provide engineers with a risk-based monitoring view of all trial sites, showing which sites are green (on track), yellow (attention needed), or red (intervention required), using the exact thresholds from the trial site monitor tool.

**Data source file:** `tools/trial-site-monitor/trial_site_monitor.py` — Contains `DEFAULT_THRESHOLDS` dict: `min_screening_ratio: 0.30`, `max_screen_failure_rate: 0.70`, `max_protocol_deviation_rate: 0.10`, `min_data_completeness: 90.0`, `max_query_rate: 5.0`, `max_enrollment_gap_days: 30`, `min_monthly_enrollment: 1.0`, `max_ae_reporting_delay_days: 3`. Also contains `SiteMetrics` dataclass and status classification logic: Green (0 flags), Yellow (1–2 flags), Red (≥3 flags).

**Table columns:** Site ID, Institution, Screened, Enrolled, Screen Failure Rate (%), Monthly Enrollment, Data Completeness (%), Query Rate/Subject, Protocol Deviations, Deviation Rate, AE Delay (days), Days Since Last Enrollment, Flags, Status

**Data to plot (example from tool defaults and logic):**
| Site | Institution | Screened | Enrolled | Failure% | Monthly Enroll | Data Complete% | Query Rate | Deviations | Dev Rate | AE Delay | Days Gap | Flags | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SITE-001 | Hospital Alpha | 45 | 15 | 67% | 2.1 | 92% | 3.2 | 1 | 0.07 | 2.1 | 8 | 0 | GREEN |
| SITE-002 | Hospital Beta | 28 | 5 | 82% | 0.7 | 87% | 5.4 | 2 | 0.40 | 3.5 | 35 | 5 | RED |
| SITE-003 | Hospital Gamma | 38 | 12 | 68% | 1.5 | 94% | 2.8 | 1 | 0.08 | 1.5 | 12 | 0 | GREEN |
| SITE-004 | Hospital Delta | 32 | 8 | 75% | 0.9 | 89% | 4.8 | 1 | 0.13 | 2.8 | 22 | 2 | YELLOW |

Color cells that violate thresholds in red, borderline in yellow, passing in green. Status column: GREEN/YELLOW/RED with background color.

**Light mode:** `plotly_white`, green=#2ecc71, yellow=#f39c12, red=#e74c3c, white cell backgrounds.
**Dark mode:** `plotly_dark`, green=#27ae60, yellow=#e67e22, red=#c0392b, dark gray cell backgrounds.

---

## Instruction 23 — Federated Learning Algorithm Comparison Radar

**Chart type:** Radar chart (`go.Scatterpolar`, fill='toself', 3 traces)

**Title:** `"Federated Aggregation Algorithms: FedAvg vs FedProx vs SCAFFOLD"`

**Purpose:** Compare the three federated learning algorithms implemented in the repository across key operational dimensions, helping engineers choose the right strategy for their multi-site trial.

**Data source files:**
- `federation/federated_coordinator.py` — Implements all three: `_aggregate_fedavg()` (weighted average by patient count), `_aggregate_fedprox()` (adds proximal term mu=0.01 for straggler robustness), `_aggregate_scaffold()` (variance-reduced with control variates tracking client drift)
- `federation/README.md` — Overview of algorithms
- `federation/differential_privacy.py` — Differential privacy integration (epsilon-delta budgets)
- `federation/secure_aggregation.py` — Secure multi-party computation

**Radar axes (5 dimensions, each scored 1–10):**
| Dimension | FedAvg | FedProx | SCAFFOLD |
|---|---|---|---|
| Convergence Speed | 7 | 7 | 9 |
| Communication Efficiency | 8 | 7 | 6 |
| Heterogeneity Handling | 4 | 7 | 9 |
| Implementation Simplicity | 9 | 7 | 5 |
| Privacy Compatibility | 8 | 8 | 7 |

Scores rationale (annotate in legend or footnote):
- FedAvg: Simple weighted average, fast but struggles with non-IID data
- FedProx: Adds proximal regularization (mu=0.01), handles stragglers
- SCAFFOLD: Uses control variates, best for heterogeneous sites but complex

**Light mode:** `plotly_white`, FedAvg=blue, FedProx=green, SCAFFOLD=red, 0.2 opacity fill.
**Dark mode:** `plotly_dark`, FedAvg=cyan, FedProx=lime, SCAFFOLD=magenta, 0.15 opacity fill.

---

## Instruction 24 — FDA AI/ML Device Classification Decision Flowchart

**Chart type:** Tree diagram using Plotly graph objects (`go.Scatter` with lines and text annotations positioned as a decision tree, or use `plotly.figure_factory` treemap alternative — use positioned scatter nodes with connecting lines)

**Title:** `"FDA AI/ML Device Classification Pathway Decision Tree for Oncology"`

**Purpose:** Map the regulatory pathway decision logic from device type to FDA submission pathway, using the exact classification rules from the repository's classification advisor.

**Data source file:** `regulatory-submit/classification_advisor.py` — Contains `DEVICE_TYPE_BASELINE` dict mapping device types to class/pathway/SW risk/product codes, and `_check_escalation_factors()` method with escalation rules for autonomous operation, patient contact, life-threatening conditions, and novel algorithms.

**Tree structure (top to bottom, 3 levels):**

**Level 1 (Root):** "AI/ML Oncology Device"

**Level 2 (Device Types, 9 nodes):**
| Node | Baseline Class | Baseline Pathway | SW Risk |
|---|---|---|---|
| CADe (Detection) | II | 510(k) | B |
| CADx (Diagnosis) | II | De Novo | B |
| CADt (Triage) | II | De Novo | C |
| Treatment Planning | II | De Novo | C |
| Prognostic | II | De Novo | B |
| Surgical Guidance | II | De Novo | C |
| Robotic Control | II | De Novo | C |
| Digital Twin | II | De Novo | C |
| Dose Optimization | II | 510(k) | C |

**Level 3 (Escalation factors, branching from each):**
- "Autonomous operation (no clinician)" → Class III, PMA
- "Patient contact" → Add IEC 80601-2-77
- "Life-threatening condition" → Breakthrough Device eligible
- "Novel algorithm (no predicate)" → De Novo (blocks 510(k))

Position nodes as X,Y coordinates in a tree layout. Connect with lines. Color by pathway: 510(k)=blue, De Novo=green, PMA=red, Breakthrough=gold.

**Light mode:** `plotly_white`, nodes as colored rectangles with dark text.
**Dark mode:** `plotly_dark`, nodes as colored rectangles with white text.

---

## Instruction 25 — FDA-Authorized AI/ML Oncology Device Distribution

**Chart type:** Horizontal stacked bar chart (single bar) + pie chart inset (`go.Bar` + `go.Pie`)

**Title:** `"FDA-Authorized AI/ML Devices in Oncology: Category Distribution (1,300+ as of Dec 2025)"`

**Purpose:** Show the landscape of FDA-authorized AI/ML oncology devices by clinical subspecialty, giving engineers context for where regulatory precedent exists.

**Data source files:**
- `agentic-ai/results.md` — Section referencing "1,300+ FDA AI/ML authorized devices as of Dec 2025"
- `regulatory-submit/classification_advisor.py` — Contains product codes (QBS, QDQ, QMT, QAS, MUJ, NQR, NAY, IYO) and recent approvals
- `regulatory/fda-compliance/fda_submission_tracker.py` — FDA submission tracking with pathway categories
- `regulatory/regulatory-intelligence/regulatory_tracker.py` — Multi-jurisdiction tracking

**Data to plot:**
| Oncology Subspecialty | Percentage | Approx Count |
|---|---|---|
| Cancer Radiology (CT/MRI/Mammography) | 54.9% | ~714 |
| Pathology (Digital/Computational) | 19.7% | ~256 |
| Radiation Oncology | 8.5% | ~111 |
| Gastroenterology (Endoscopy AI) | 8.5% | ~111 |
| Clinical Oncology (Prognostic/Treatment) | 7.0% | ~91 |
| Other | 1.4% | ~18 |

Also annotate recent oncology approvals:
- ArteraAI Prostate (Aug 2025, De Novo)
- Allix5 Breast Cancer Risk (May 2025)
- Serial CTRS NSCLC (Feb 2025, Breakthrough)

**Light mode:** `plotly_white`, distinct muted colors per category.
**Dark mode:** `plotly_dark`, distinct bright colors per category.

---

## Instruction 26 — Regulatory Compliance Checklist Scorecard

**Chart type:** Annotated heatmap / table hybrid (`ff.create_annotated_heatmap` or `go.Heatmap` with text)

**Title:** `"Regulatory Compliance Scorecard: IEC 62304 + FDA AI/ML + ISO 14971"`

**Purpose:** Present the complete regulatory checklist matrix showing all compliance items across three major standards, their descriptions, and completion status categories.

**Data source file:** `tools/deployment-readiness/deployment_readiness.py` — Contains three checklist dicts: `IEC_62304_CHECKLIST` (8 items), `FDA_AIML_CHECKLIST` (6 items), `ISO_14971_CHECKLIST` (5 items), each with item ID, description, and category.

**Heatmap structure:** Rows = checklist items (19 total); Columns = attributes (Standard, Item ID, Description, Category); Color by Standard (green for IEC 62304, blue for FDA AI/ML, orange for ISO 14971).

**Data to plot:**

**IEC 62304 Software Lifecycle (8 items):**
| Item ID | Description | Category |
|---|---|---|
| 62304-5.1 | Software development planning | Planning |
| 62304-5.2 | Software requirements analysis | Requirements |
| 62304-5.3 | Software architectural design | Design |
| 62304-5.5 | Software integration and testing | Testing |
| 62304-5.7 | Software release | Release |
| 62304-7.1 | Risk analysis for software items | Risk |
| 62304-8 | Software configuration management | Config |
| 62304-9 | Software problem resolution | Maintenance |

**FDA AI/ML PCCP (6 items):**
| Item ID | Description | Category |
|---|---|---|
| PCCP-1 | Modification protocol | Change Control |
| PCCP-2 | Performance monitoring plan | Monitoring |
| PCCP-3 | Update validation protocol | Validation |
| PCCP-4 | Data management governance | Data |
| PCCP-5 | Transparency/labeling documentation | Transparency |
| PCCP-6 | Bias evaluation across demographics | Equity |

**ISO 14971 Risk Management (5 items):**
| Item ID | Description | Category |
|---|---|---|
| 14971-4 | Hazard identification & risk estimation | Analysis |
| 14971-5 | Risk acceptability evaluation | Evaluation |
| 14971-6 | Risk control measures | Control |
| 14971-7 | Residual risk & benefit-risk analysis | Residual |
| 14971-9 | Post-production monitoring | Post-Market |

**Light mode:** `plotly_white`, IEC cells=light green, FDA cells=light blue, ISO cells=light orange, text in black.
**Dark mode:** `plotly_dark`, IEC cells=dark green, FDA cells=dark blue, ISO cells=dark orange, text in white.

---

## Instruction 27 — HIPAA PHI Detection Confidence & Risk Matrix

**Chart type:** Annotated heatmap (`go.Heatmap` with text annotations)

**Title:** `"HIPAA PHI Detection: 18 Identifier Types — Confidence & Risk Stratification"`

**Purpose:** Show engineers which PHI types the detection system handles with high confidence versus those requiring more careful handling, mapped against clinical risk levels.

**Data source file:** `privacy/phi-pii-management/phi_detector.py` — Contains `HIPAA_IDENTIFIERS` dict with all 18 identifier types, pattern matching logic, and `_calculate_confidence()` method. Also contains `_stratify_risk()` with Critical/High/Medium/Low categories.

**Heatmap axes:**
- Y-axis (rows): 18 HIPAA identifiers
- X-axis (columns): Detection Confidence (0.0–1.0), Risk Level (encoded 1–4)

**Data to plot:**
| Identifier | Detection Confidence | Risk Level | Risk Category |
|---|---|---|---|
| NAME | 0.92 | 4 | Critical |
| GEOGRAPHIC_DATA | 0.85 | 3 | High |
| DATES | 0.80 | 3 | High |
| PHONE_NUMBERS | 0.85 | 3 | High |
| FAX_NUMBERS | 0.82 | 2 | Medium |
| EMAIL_ADDRESSES | 0.95 | 3 | High |
| SOCIAL_SECURITY_NUMBERS | 0.98 | 4 | Critical |
| MEDICAL_RECORD_NUMBERS | 0.95 | 4 | Critical |
| HEALTH_PLAN_BENEFICIARY | 0.90 | 3 | High |
| ACCOUNT_NUMBERS | 0.90 | 2 | Medium |
| CERTIFICATE_LICENSE | 0.78 | 2 | Medium |
| VEHICLE_IDENTIFIERS | 0.75 | 1 | Low |
| DEVICE_IDENTIFIERS | 0.80 | 2 | Medium |
| WEB_URLS | 0.88 | 2 | Medium |
| IP_ADDRESSES | 0.85 | 2 | Medium |
| BIOMETRIC_IDENTIFIERS | 0.70 | 3 | High |
| FULL_FACE_PHOTOGRAPHS | 0.65 | 3 | High |
| UNIQUE_IDENTIFYING_CODES | 0.72 | 2 | Medium |

Color cells by: confidence (green high → red low). Text annotation in each cell: confidence value + risk category.

Add annotation: "Critical Risk = Immediate escalation (Name+MRN combo, SSN detected)".

**Light mode:** `plotly_white`, green-yellow-red confidence scale, bold text for Critical items.
**Dark mode:** `plotly_dark`, teal-amber-crimson confidence scale, bold text for Critical items.

---

## Instruction 28 — Privacy-Preserving Analytics Pipeline: Step-by-Step Process

**Chart type:** Horizontal segmented bar / process flow using positioned rectangles and arrows (`go.Scatter` with shapes and annotations for a pipeline diagram)

**Title:** `"Privacy-Preserving Analytics Pipeline: From Raw Clinical Data to Publishable Results"`

**Purpose:** Map the complete data privacy pipeline from raw clinical data to analytics output, showing each transformation step and the privacy guarantees applied, so engineers understand the end-to-end data governance workflow.

**Data source files (one per pipeline stage):**
- Stage 1: `privacy/phi-pii-management/phi_detector.py` — PHI detection (18 HIPAA identifiers, pattern + NER)
- Stage 2: `privacy/de-identification/deidentification_pipeline.py` — Safe Harbor (18-identifier removal) and Expert Determination (statistical re-ID risk < threshold) per 45 CFR 164.514
- Stage 3: `federation/differential_privacy.py` — Epsilon-delta budgets, Gaussian/Laplacian noise mechanisms
- Stage 4: `federation/secure_aggregation.py` — Simulated secure multi-party computation (secret sharing)
- Stage 5: `federation/privacy_analytics.py` — Privacy-preserving Kaplan-Meier survival analysis, Cox proportional hazards, response rate estimation
- Access control: `privacy/access-control/access_control_manager.py` — RBAC with 21 CFR Part 11 audit trail
- Breach response: `privacy/breach-response/breach_response_protocol.py` — Incident detection and notification

**Pipeline stages to draw (6 rectangles connected by arrows, left to right):**
| Stage | Label | Key Detail | Privacy Guarantee |
|---|---|---|---|
| 1 | Raw Clinical Data | DICOM, FHIR R4, HL7 v2 | None (PHI present) |
| 2 | PHI Detection | 18 HIPAA identifiers scanned | Detection confidence: 0.65–0.98 |
| 3 | De-Identification | Safe Harbor or Expert Determination | Re-ID risk < threshold |
| 4 | Differential Privacy | ε-δ noise injection | Formal ε-δ guarantee |
| 5 | Secure Aggregation | Multi-party computation | No single party sees raw data |
| 6 | Privacy Analytics | KM, Cox PH, Response Rates | Publishable aggregate results |

Draw an arrow labeled "21 CFR Part 11 Audit Trail" running along the bottom connecting all stages. Draw a shield icon or annotation at each stage showing the privacy mechanism.

**Light mode:** `plotly_white`, stages in graduated blue (light→dark), arrows in gray.
**Dark mode:** `plotly_dark`, stages in graduated cyan (light→bright), arrows in white.

---

## Instruction 29 — Deployment Readiness Assessment: Multi-Dimensional Radar + Benchmarks

**Chart type:** Radar chart with table inset (`make_subplots` with `go.Scatterpolar` + `go.Table`)

**Title:** `"Deployment Readiness Assessment: ONNX Model Validation & Safety Compliance"`

**Purpose:** Provide engineers with a comprehensive readiness view combining model performance benchmarks, safety constraint verification, and regulatory checklist status.

**Data source file:** `tools/deployment-readiness/deployment_readiness.py` — Contains `run_benchmark()` (ONNX validation, latency testing), `check_safety_constraints()` (force/velocity/workspace/latency limits), `run_regulatory_checklists()` (IEC 62304, ISO 14971, FDA AI/ML). Also contains example output structure.

**Radar chart (6 axes, score 0–100):**
| Dimension | Score | Source Detail |
|---|---|---|
| ONNX Compatibility | 100 | Valid ONNX, opset 17, CPU+CUDA runtime (from `deployment_readiness.py`) |
| Latency Budget | 77 | Mean 23.456ms vs 100ms budget → 77% margin (from benchmark results) |
| Force Safety | 96 | 96.5% trajectories within 5N limit (from `reinforcement-learning/results.md`) |
| Velocity Safety | 100 | 99.8% within 0.1 m/s limit (from `reinforcement-learning/results.md`) |
| Workspace Bounds | 100 | 99.9% within [-0.3,0.3]×[-0.3,0.3]×[0,0.6]m (from `configs/training_config.yaml`) |
| Regulatory Readiness | 68 | 13/19 checklist items addressed (from deployment readiness tool) |

**Table inset — Benchmark results:**
| Metric | Value | Threshold | Status |
|---|---|---|---|
| Mean Latency | 23.456 ms | <100 ms | PASS |
| P95 Latency | 34.127 ms | <100 ms | PASS |
| P99 Latency | 42.890 ms | <100 ms | PASS |
| Throughput | 42.6 FPS | >10 FPS | PASS |
| Model Size | 142.5 MB | N/A | — |
| Graph Nodes | 847 | N/A | — |
| Validation Passed | 40/42 | 100% | REVIEW |

**Light mode:** `plotly_white`, radar fill=light blue with 0.3 opacity, table with white background.
**Dark mode:** `plotly_dark`, radar fill=cyan with 0.2 opacity, table with dark background.

---

## Instruction 30 — Production Readiness by Surgical Task Category

**Chart type:** Horizontal bar chart with threshold lines and status color coding (`go.Bar` orientation='h')

**Title:** `"Surgical Task Production Readiness: From Research to Deployment"`

**Purpose:** Summarize the maturity level of each surgical task category, with clear deployment threshold markers so engineers know which capabilities are production-ready and which require further research.

**Data source files:**
- `reinforcement-learning/results.md` — Section: "Production Readiness Assessment": Basic manipulation 98%, Precision grasping 91%, Tissue interaction 84%, Suturing 78%, Complex procedures 65%
- `supervised-learning/results.md` — Section: "Production Readiness": Instrument detection 94.8% (ready), Phase recognition 94.2% (ready), Anatomical segmentation 97.2% (ready), Skill assessment 91.2% (partial), Anomaly detection 94% AUC (partial), Depth estimation 96.8% (ready), Pose estimation 94% (ready)
- `self-supervised-learning/results.md` — Section: "Production Readiness": Instrument detection 96%, Phase recognition 94%, Tissue segmentation 89%, Action recognition 85%, Autonomous control 78%
- `generative-ai/results.md` — OOD detection: Novel anatomy 89%, Unusual bleeding 76%, Instrument malfunction 94%, Lighting anomaly 98%

**X-axis label:** `"Success Rate / Readiness Score (%)"`
**Y-axis label:** `"Task Category"`

**Data to plot (combined view, sorted by readiness):**
| Category | Readiness (%) | Status | Source |
|---|---|---|---|
| Basic Manipulation (RL) | 98 | Deploy Ready | reinforcement-learning/results.md |
| Anatomical Segmentation (SL) | 97.2 | Deploy Ready | supervised-learning/results.md |
| Instrument Detection (SSL) | 96 | Deploy Ready | self-supervised-learning/results.md |
| Depth Estimation (SL) | 96.8 | Deploy Ready | supervised-learning/results.md |
| Instrument Detection (SL) | 94.8 | Deploy Ready | supervised-learning/results.md |
| Phase Recognition (SL) | 94.2 | Deploy Ready | supervised-learning/results.md |
| Pose Estimation (SL) | 94 | Deploy Ready | supervised-learning/results.md |
| Precision Grasping (RL) | 91 | Supervised Use | reinforcement-learning/results.md |
| Skill Assessment (SL) | 91.2 | Supervised Use | supervised-learning/results.md |
| Tissue Segmentation (SSL) | 89 | Supervised Use | self-supervised-learning/results.md |
| Action Recognition (SSL) | 85 | Limited/Research | self-supervised-learning/results.md |
| Tissue Interaction (RL) | 84 | Limited/Research | reinforcement-learning/results.md |
| Suturing (RL) | 78 | Research Only | reinforcement-learning/results.md |
| Autonomous Control (SSL) | 78 | Research Only | self-supervised-learning/results.md |
| Complex Procedures (RL) | 65 | Research Only | reinforcement-learning/results.md |

Add vertical dashed line at 90% labeled "Deployment Threshold". Add vertical dashed line at 80% labeled "Supervised Use Threshold". Color bars: ≥90% green (Deploy Ready), 80–89% yellow (Supervised), <80% red (Research Only).

**Light mode:** `plotly_white`, green=#2ecc71, yellow=#f1c40f, red=#e74c3c, threshold lines in black dashed.
**Dark mode:** `plotly_dark`, green=#27ae60, yellow=#f39c12, red=#e74c3c, threshold lines in white dashed.

### Follow-Up Prompt
Finish
